California Pacific Medical Center

  • Home
  • Employment
  • About Us
  • Find a Physician
  • Services
  • Health Information
  • For Health Professionals
  • Giving & Volunteering
  • Quality

For Health Professionals

  • Research
    • Technology Transfer
      • About Us
      • Technology Transfer Process
      • Research Programs
      • Contact Us



Tracheobronchial Gland Epithelial Cell Lines

  • Decrease Font Size
  • Increase Font Size
  • Send to a Friend
  • Share
    • Share / Blog
    • Digg This
    • del.icio.us
    • Newsvine
    • Facebook
    • Reddit
    • Furl It
    • !Y My Web
    • Google
  • Print
Background  |  Applications  |  Advantages  |  Description  |  Patents and Publications  |  Technology Reference Number

Background



Cystic Fibrosis is a genetic disorder that affects the respiratory, digestive and reproductive systems. There are approximately 30,000 people in the United States with CF and approximately 2,500 new cases diagnosed each year. Currently, there is no cure for CF. These cell lines were created as part of an ultimate aim of developing genetic and pharmacological therapies for cystic fibrosis.


Back to top

Applications



These cell lines can be used to determine the role of CFTR, to define therapeutic agents that can correct mutant CFTR function, and to develop therapeutic modalities to treat CF pathology.



Back to top

Advantages



The parental cell line CFSMEo- was derived from preparation of airway bronchial submucosal gland epithelial cell and is immortalized with an origin of replication defective SV 40 virus-containing plasmid. The cells have unlimited growth potential, have tight junctions, and a F508/ Q2X CF genotype.


Back to top

Description



Bronchial Epithelial Cell Lines (CFSMEo) - parental cell line.

2005-293
CFSMEo-/CEP-CFTR 4.7: A CF submucosal gland-derived cell line complemented with a 4.7 Kb wild type CFTR cDNA

2005-294
CFSMEo-/CEP-CFTR 6.2: A CF submucosal gland-derived cell line complemented with a 6.2 Kb wild type CFTR cDNA

2005-295
CFSMEo-/CEP-CFTR F4.7: A CF submucosal gland-derived cell line complemented with a 4.7 Kb F508 CFTR cDNA

_______________________________________________

Bronchial Epithelial Cell Lines (6CFSMEo-) - daughter cell line.

2005-299
6CFSMEo-/CEP-CFTR F4.7: A CF submucosal gland-derived cell line complemented with a 4.7 Kb F508 CFTR cDNA

2005-300
6CFSMEo-/CEP-CFTR 4.7: A CF submucosal gland-derived cell line complemented with a 4.7 Kb wild type CFTR cDNA

2005-301
6CFSMEo-/CEP-CFTR 6.2: A CF submucosal gland-derived cell line complemented with a 6.2 Kb wild type CFTR cDNA

Back to top

Patents and Publications







Back to top

Technology Reference Number



G-101104a

Back to top

shim
> Colon Cancer Diagnostic Kit

> Novel Anticancer Drugs

> Therapeutics for Invasive and Metastatic Cancers

> ClearVisionTM

> Tracheobronchial Gland Epithelial Cell Lines

> Bronchial Epithelial Cell Lines

> Novel Immortal Cell Lines

> Development of Human Cancer Vaccines in Pre-Clinical Mouse Tumor Models

> Cell Lines For The Study of Respiratory Diseases

> Breast Cancer Risk Assessment through Mammographic Density Measurements
  • About Our Sutter Health Network
  • Contact Us
  • Privacy Policy
  • Accessibility
  • Site Map

© 2008 California Pacific Medical Center. All rights reserved.